Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Roger Douglas Weiss, M.D.

Title
Institution
Department
Address
Phone
Fax

Research
research activities and funding
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
Most Recent  |  List All
  1. R21DA041682 (CHAN, KEVIN E) Mar 15, 2017 - Feb 28, 2019
    NIH/NIDA
    Opioid Use and Abuse in the Dialysis Population
    Role: Co-Principal Investigator
  2. K24DA022288 (WEISS, ROGER D.) Apr 1, 2007 - Aug 31, 2017
    NIH/NIDA
    Mentoring in drug abuse and dual diagnosis research
    Role: Principal Investigator
  3. UG1DA015831 (WEISS, ROGER D.) Sep 30, 2002 - May 31, 2020
    NIH/NIDA
    The National Drug Abuse Treatment Clinical Trials Network
    Role: Co-Principal Investigator
  4. U10DA015831 (WEISS, ROGER D.) Sep 30, 2002 - Aug 31, 2015
    NIH/NIDA
    The National Drug Abuse Treatment Clinical Trials Network (U10)
    Role: Co-Principal Investigator
  5. R01DA015968 (WEISS, ROGER D.) Sep 30, 2002 - Jan 31, 2009
    NIH/NIDA
    Modifying Group Therapy for Bipolar Abusers
    Role: Principal Investigator

Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Beckwith N, McDowell MJ, Reisner SL, Zaslow S, Weiss RD, Mayer KH, Keuroghlian AS. Psychiatric Epidemiology of Transgender and Nonbinary Adult Patients at an Urban Health Center. LGBT Health. 2019 Feb 01. PMID: 30707624.
    Citations:    Fields:    
  2. Kiluk BD, Fitzmaurice GM, Strain EC, Weiss RD. Response to commentaries: The quest(ion) remains in the search for a meaningful reduction-based end-point. Addiction. 2019 Jan; 114(1):21-23. PMID: 30474162.
    Citations:    Fields:    
  3. Connery HS, Weiss RD. Microscopes and Telescopes: the Societal Impact of Substance Use Disorder Treatment. Am J Psychiatry. 2018 Oct 01; 175(10):925-926. PMID: 30269546.
    Citations:    Fields:    
  4. Fitzmaurice GM, Lipsitz SR, Weiss RD. Sensitivity analysis for non-monotone missing binary data in longitudinal studies: Application to the NIDA collaborative cocaine treatment study. Stat Methods Med Res. 2018 Aug 27; 962280218794725. PMID: 30146938.
    Citations:    Fields:    
  5. McHugh RK, Geyer R, Karakula S, Griffin ML, Weiss RD. Nonmedical benzodiazepine use in adults with alcohol use disorder: The role of anxiety sensitivity and polysubstance use. Am J Addict. 2018 Sep; 27(6):485-490. PMID: 30028048.
    Citations:    Fields:    
  6. Kiluk BD, Fitzmaurice GM, Strain EC, Weiss RD. What defines a clinically meaningful outcome in the treatment of substance use disorders: reductions in direct consequences of drug use or improvement in overall functioning? Addiction. 2019 Jan; 114(1):9-15. PMID: 29900624.
    Citations:    
  7. Welsh JW, Tretyak V, McHugh RK, Weiss RD, Bogunovic O. Review: Adjunctive pharmacologic approaches for benzodiazepine tapers. Drug Alcohol Depend. 2018 08 01; 189:96-107. PMID: 29906718.
    Citations:    Fields:    Translation:Humans
  8. Fitzmaurice GM, Lipsitz SR, Weiss RD. Statistical considerations in the choice of endpoint for drug use disorder trials. Drug Alcohol Depend. 2017 12 01; 181:219-222. PMID: 29102827.
    Citations:    Fields:    Translation:Humans
  9. Hill KP, Palastro MD, Gruber SA, Fitzmaurice GM, Greenfield SF, Lukas SE, Weiss RD. Nabilone pharmacotherapy for cannabis dependence: A randomized, controlled pilot study. Am J Addict. 2017 Dec; 26(8):795-801. PMID: 28921814.
    Citations:    Fields:    Translation:Humans
  10. Liebschutz JM, Xuan Z, Shanahan CW, LaRochelle M, Keosaian J, Beers D, Guara G, O'Connor K, Alford DP, Parker V, Weiss RD, Samet JH, Crosson J, Cushman PA, Lasser KE. Improving Adherence to Long-term Opioid Therapy Guidelines to Reduce Opioid Misuse in Primary Care: A Cluster-Randomized Clinical Trial. JAMA Intern Med. 2017 09 01; 177(9):1265-1272. PMID: 28715535.
    Citations: 4     Fields:    Translation:Humans
  11. Medlock MM, Rosmarin DH, Connery HS, Griffin ML, Weiss RD, Karakula SL, McHugh RK. Religious coping in patients with severe substance use disorders receiving acute inpatient detoxification. Am J Addict. 2017 Oct; 26(7):744-750. PMID: 28836712.
    Citations:    Fields:    Translation:Humans
  12. McHugh RK, Votaw VR, Barlow DH, Fitzmaurice GM, Greenfield SF, Weiss RD. Development of an integrated cognitive behavioral therapy for anxiety and opioid use disorder: Study protocol and methods. Contemp Clin Trials. 2017 09; 60:105-112. PMID: 28689852.
    Citations: 1     Fields:    Translation:Humans
  13. Greenfield SF, Weiss RD. Addiction-25 Years Later. Harv Rev Psychiatry. 2017 May/Jun; 25(3):97-100. PMID: 28475500.
    Citations:    Fields:    Translation:Humans
  14. Weiss RD, Rao V. The Prescription Opioid Addiction Treatment Study: What have we learned. Drug Alcohol Depend. 2017 04 01; 173 Suppl 1:S48-S54. PMID: 28363320.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  15. McHugh RK, Votaw VR, Fulciniti F, Connery HS, Griffin ML, Monti PM, Weiss RD. Perceived barriers to smoking cessation among adults with substance use disorders. J Subst Abuse Treat. 2017 03; 74:48-53. PMID: 28132700.
    Citations: 1     Fields:    Translation:Humans
  16. Carroll KM, Weiss RD. The Role of Behavioral Interventions in Buprenorphine Maintenance Treatment: A Review. Am J Psychiatry. 2017 08 01; 174(8):738-747. PMID: 27978771.
    Citations: 7     Fields:    Translation:Humans
  17. Griffin ML, McDermott KA, McHugh RK, Fitzmaurice GM, Weiss RD. Grit in patients with substance use disorders. Am J Addict. 2016 Dec; 25(8):652-658. PMID: 27759947.
    Citations: 1     Fields:    
  18. Karakula SL, Weiss RD, Griffin ML, Borges AM, Bailey AJ, McHugh RK. Delay discounting in opioid use disorder: Differences between heroin and prescription opioid users. Drug Alcohol Depend. 2016 12 01; 169:68-72. PMID: 27776247.
    Citations: 2     Fields:    Translation:Humans
  19. Mackie SE, McHugh RK, McDermott K, Griffin ML, Winkelman JW, Weiss RD. Prevalence of restless legs syndrome during detoxification from alcohol and opioids. J Subst Abuse Treat. 2017 02; 73:35-39. PMID: 28017182.
    Citations: 1     Fields:    Translation:Humans
  20. McHugh RK, Votaw VR, Bogunovic O, Karakula SL, Griffin ML, Weiss RD. Anxiety sensitivity and nonmedical benzodiazepine use among adults with opioid use disorder. Addict Behav. 2017 02; 65:283-288. PMID: 27575980.
    Citations: 2     Fields:    Translation:Humans
  21. Votaw VR, Wittenauer J, Connery HS, Weiss RD, McHugh RK. Perceived risk of heroin use among nonmedical prescription opioid users. Addict Behav. 2017 02; 65:218-223. PMID: 27544695.
    Citations: 3     Fields:    Translation:Humans
  22. Hill KP, Weiss RD. Minimal Physical Health Risk Associated With Long-term Cannabis Use--But Buyer Beware. JAMA. 2016 Jun 07; 315(21):2338-9. PMID: 27272585.
    Citations: 3     Fields:    Translation:HumansAnimals
  23. Griffin ML, McDermott KA, McHugh RK, Fitzmaurice GM, Jamison RN, Weiss RD. Longitudinal association between pain severity and subsequent opioid use in prescription opioid dependent patients with chronic pain. Drug Alcohol Depend. 2016 06 01; 163:216-21. PMID: 27161860; PMCID: PMC4880512.
    Citations: 3     Fields:    Translation:Humans
  24. McHugh RK, Weiss RD, Cornelius M, Martel MO, Jamison RN, Edwards RR. Distress Intolerance and Prescription Opioid Misuse Among Patients With Chronic Pain. J Pain. 2016 07; 17(7):806-14. PMID: 27058161; PMCID: PMC4925301.
    Citations: 6     Fields:    Translation:Humans
  25. McHugh RK, Fitzmaurice GM, Griffin ML, Anton RF, Weiss RD. Association between a brief alcohol craving measure and drinking in the following week. Addiction. 2016 06; 111(6):1004-10. PMID: 26780476.
    Citations: 3     Fields:    Translation:Humans
  26. Sylvia LG, Gold AK, Stange JP, Peckham AD, Deckersbach T, Calabrese JR, Weiss RD, Perlis RH, Nierenberg AA, Ostacher MJ. A randomized, placebo-controlled proof-of-concept trial of adjunctive topiramate for alcohol use disorders in bipolar disorder. Am J Addict. 2016 Mar; 25(2):94-8. PMID: 26894822; PMCID: PMC4791182.
    Citations: 5     Fields:    Translation:Humans
  27. McHugh RK, Fulciniti F, Mashhoon Y, Weiss RD. Cue-induced craving to paraphernalia and drug images in opioid dependence. Am J Addict. 2016 Mar; 25(2):105-9. PMID: 26848719; PMCID: PMC4883011.
    Citations:    Fields:    Translation:Humans
  28. Copersino ML, Price JS, Frost KH, Vitaliano GD, Frederick BD, Lukas SE, Weiss RD, Janes AC. Default Mode Network Functional Reorganization During Early Abstinence in Polysubstance-Using Emerging Adults Treated for Opioid Dependence. J Neuropsychiatry Clin Neurosci. 2016 Jan 21; appineuropsych15090240. PMID: 26792100.
    Citations:    Fields:    
  29. Nosyk B, Bray JW, Wittenberg E, Aden B, Eggman AA, Weiss RD, Potter J, Ang A, Hser YI, Ling W, Schackman BR. Short term health-related quality of life improvement during opioid agonist treatment. Drug Alcohol Depend. 2015 Dec 01; 157:121-8. PMID: 26511766; PMCID: PMC4778423.
    Citations: 2     Fields:    Translation:Humans
  30. Keuroghlian AS, Reisner SL, White JM, Weiss RD. Substance use and treatment of substance use disorders in a community sample of transgender adults. Drug Alcohol Depend. 2015 Jul 01; 152:139-46. PMID: 25953644; PMCID: PMC4458188.
    Citations: 11     Fields:    Translation:Humans
  31. Griffin ML, Bennett HE, Fitzmaurice GM, Hill KP, Provost SE, Weiss RD. Health-related quality of life among prescription opioid-dependent patients: Results from a multi-site study. Am J Addict. 2015 Jun; 24(4):308-14. PMID: 25808055; PMCID: PMC4593699.
    Citations: 4     Fields:    Translation:Humans
  32. Weiss RD, Potter JS, Griffin ML, Provost SE, Fitzmaurice GM, McDermott KA, Srisarajivakul EN, Dodd DR, Dreifuss JA, McHugh RK, Carroll KM. Long-term outcomes from the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment Study. Drug Alcohol Depend. 2015 May 01; 150:112-9. PMID: 25818060; PMCID: PMC4407806.
    Citations: 17     Fields:    Translation:Humans
  33. Greenfield SF, Weiss RD. Harvard Review of Psychiatry. Introduction. Harv Rev Psychiatry. 2015 Mar-Apr; 23(2):61-2. PMID: 25747919.
    Citations:    Fields:    Translation:Humans
  34. DeVido J, Bogunovic O, Weiss RD. Alcohol use disorders in pregnancy. Harv Rev Psychiatry. 2015 Mar-Apr; 23(2):112-21. PMID: 25747924; PMCID: PMC4530607.
    Citations: 6     Fields:    Translation:Humans
  35. Hearon BA, Pierce CL, Björgvinsson T, Fitzmaurice GM, Greenfield SF, Weiss RD, Busch AB. Improving the efficiency of drug use disorder screening in psychiatric settings: validation of a single-item screen. Am J Drug Alcohol Abuse. 2015 Mar; 41(2):173-6. PMID: 25700005.
    Citations:    Fields:    Translation:HumansPHPublic Health
  36. McDermott KA, Griffin ML, Connery HS, Hilario EY, Fiellin DA, Fitzmaurice GM, Weiss RD. Initial response as a predictor of 12-week buprenorphine-naloxone treatment response in a prescription opioid-dependent population. J Clin Psychiatry. 2015 Feb; 76(2):189-94. PMID: 25562462; PMCID: PMC4352119.
    Citations: 4     Fields:    Translation:Humans
  37. Suzuki J, DeVido J, Kalra I, Mittal L, Shah S, Zinser J, Weiss RD. Initiating buprenorphine treatment for hospitalized patients with opioid dependence: A case series. Am J Addict. 2015 Jan; 24(1):10-4. PMID: 25823630.
    Citations: 4     Fields:    Translation:Humans
  38. Suzuki J, DeVido J, Kalra I, Mittal L, Shah S, Zinser J, Weiss RD. Initiating buprenorphine treatment for hospitalized patients with opioid dependence: A case series. Am J Addict. 2014 Nov 06. PMID: 25376754.
    Citations:    
  39. McHugh RK, Fitzmaurice GM, Carroll KM, Griffin ML, Hill KP, Wasan AD, Weiss RD. Assessing craving and its relationship to subsequent prescription opioid use among treatment-seeking prescription opioid dependent patients. Drug Alcohol Depend. 2014 Dec 01; 145:121-6. PMID: 25454409; PMCID: PMC4254575.
    Citations: 9     Fields:    Translation:Humans
  40. Northrup TF, Stotts AL, Green C, Potter JS, Marino EN, Walker R, Weiss RD, Trivedi M. Opioid withdrawal, craving, and use during and after outpatient buprenorphine stabilization and taper: a discrete survival and growth mixture model. Addict Behav. 2015 Feb; 41:20-8. PMID: 25282598; PMCID: PMC4252696.
    Citations: 6     Fields:    Translation:Humans
  41. Levy S, Weiss R, Sherritt L, Ziemnik R, Spalding A, Van Hook S, Shrier LA. An electronic screen for triaging adolescent substance use by risk levels. JAMA Pediatr. 2014 Sep; 168(9):822-8. PMID: 25070067; PMCID: PMC4270364.
    Citations: 10     Fields:    Translation:HumansPHPublic Health
  42. McClure EA, Sonne SC, Winhusen T, Carroll KM, Ghitza UE, McRae-Clark AL, Matthews AG, Sharma G, Van Veldhuisen P, Vandrey RG, Levin FR, Weiss RD, Lindblad R, Allen C, Mooney LJ, Haynes L, Brigham GS, Sparenborg S, Hasson AL, Gray KM. Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network. Contemp Clin Trials. 2014 Nov; 39(2):211-23. PMID: 25179587; PMCID: PMC4252394.
    Citations: 13     Fields:    Translation:Humans
  43. McHugh RK, Nielsen S, Weiss RD. Prescription drug abuse: from epidemiology to public policy. J Subst Abuse Treat. 2015 Jan; 48(1):1-7. PMID: 25239857; PMCID: PMC4250400.
    Citations: 8     Fields:    Translation:Humans
  44. Potter JS, Dreifuss JA, Marino EN, Provost SE, Dodd DR, Rice LS, Fitzmaurice GM, Griffin ML, Weiss RD. The multi-site prescription opioid addiction treatment study: 18-month outcomes. J Subst Abuse Treat. 2015 Jan; 48(1):62-9. PMID: 25189089; PMCID: PMC4250351.
    Citations: 6     Fields:    Translation:Humans
  45. Hilario EY, Griffin ML, McHugh RK, McDermott KA, Connery HS, Fitzmaurice GM, Weiss RD. Denial of urinalysis-confirmed opioid use in prescription opioid dependence. J Subst Abuse Treat. 2015 Jan; 48(1):85-90. PMID: 25115135; PMCID: PMC4250346.
    Citations: 3     Fields:    Translation:Humans
  46. Macias Konstantopoulos WL, Dreifuss JA, McDermott KA, Parry BA, Howell ML, Mandler RN, Fitzmaurice GM, Bogenschutz MP, Weiss RD. Identifying patients with problematic drug use in the emergency department: results of a multisite study. Ann Emerg Med. 2014 Nov; 64(5):516-25. PMID: 24999283; PMCID: PMC4252835.
    Citations: 10     Fields:    Translation:HumansPHPublic Health
  47. Schuman-Olivier Z, Weiss RD, Hoeppner BB, Borodovsky J, Albanese MJ. Emerging adult age status predicts poor buprenorphine treatment retention. J Subst Abuse Treat. 2014 Sep; 47(3):202-12. PMID: 24953168; PMCID: PMC4180514.
    Citations: 15     Fields:    Translation:HumansPHPublic Health
  48. Suzuki J, Matthews ML, Brick D, Nguyen MT, Wasan AD, Jamison RN, Ellner AL, Tishler LW, Weiss RD. Implementation of a collaborative care management program with buprenorphine in primary care: a comparison between opioid-dependent patients and patients with chronic pain using opioids nonmedically. J Opioid Manag. 2014 May-Jun; 10(3):159-68. PMID: 24944066; PMCID: PMC4085743.
    Citations: 1     Fields:    Translation:Humans
  49. Weiss RD, Griffin ML, Potter JS, Dodd DR, Dreifuss JA, Connery HS, Carroll KM. Who benefits from additional drug counseling among prescription opioid-dependent patients receiving buprenorphine-naloxone and standard medical management? Drug Alcohol Depend. 2014 Jul 01; 140:118-22. PMID: 24831754; PMCID: PMC4053488.
    Citations: 5     Fields:    Translation:Humans
  50. Weiss RD, Potter JS, Griffin ML, McHugh RK, Haller D, Jacobs P, Gardin J, Fischer D, Rosen KD. Reasons for opioid use among patients with dependence on prescription opioids: the role of chronic pain. J Subst Abuse Treat. 2014 Aug; 47(2):140-5. PMID: 24814051; PMCID: PMC4074437.
    Citations: 9     Fields:    Translation:Humans
  51. McHugh RK, Park S, Weiss RD. Cue-induced craving in dependence upon prescription opioids and heroin. Am J Addict. 2014 Sep-Oct; 23(5):453-8. PMID: 24628912; PMCID: PMC4163930.
    Citations: 6     Fields:    Translation:Humans
  52. Weiss RD. Behavioural treatment combined with buprenorphine does not reduce opioid use compared with buprenorphine alone. Evid Based Ment Health. 2014 May; 17(2):e2. PMID: 24591547.
    Citations:    Fields:    Translation:Humans
  53. McHugh RK, Sugarman DE, Kaufman JS, Park S, Weiss RD, Greenfield SF. Readability of self-report alcohol misuse measures. J Stud Alcohol Drugs. 2014 Mar; 75(2):328-34. PMID: 24650827; PMCID: PMC3965686.
    Citations:    Fields:    Translation:Humans
  54. McHugh RK, Hu MC, Campbell AN, Hilario EY, Weiss RD, Hien DA. Changes in sleep disruption in the treatment of co-occurring posttraumatic stress disorder and substance use disorders. J Trauma Stress. 2014 Feb; 27(1):82-9. PMID: 24473926.
    Citations: 4     Fields:    Translation:Humans
  55. Griffin ML, Dodd DR, Potter JS, Rice LS, Dickinson W, Sparenborg S, Weiss RD. Baseline characteristics and treatment outcomes in prescription opioid dependent patients with and without co-occurring psychiatric disorder. Am J Drug Alcohol Abuse. 2014 Mar; 40(2):157-62. PMID: 24219166; PMCID: PMC3947491.
    Citations: 2     Fields:    Translation:Humans
  56. Nielsen S, Hillhouse M, Weiss RD, Mooney L, Sharpe Potter J, Lee J, Gourevitch MN, Ling W. The relationship between primary prescription opioid and buprenorphine-naloxone induction outcomes in a prescription opioid dependent sample. Am J Addict. 2014 Jul-Aug; 23(4):343-8. PMID: 24112096; PMCID: PMC4151625.
    Citations: 2     Fields:    Translation:Humans
  57. Meade CS, Bevilacqua LA, Moore ED, Griffin ML, Gardin JG, Potter JS, Hatch-Maillette M, Weiss RD. Concurrent substance abuse is associated with sexual risk behavior among adults seeking treatment for prescription opioid dependence. Am J Addict. 2014 Jan-Feb; 23(1):27-33. PMID: 24313238; PMCID: PMC3914665.
    Citations: 4     Fields:    Translation:Humans
  58. Smith SM, Dart RC, Katz NP, Paillard F, Adams EH, Comer SD, Degroot A, Edwards RR, Haddox JD, Jaffe JH, Jones CM, Kleber HD, Kopecky EA, Markman JD, Montoya ID, O'Brien C, Roland CL, Stanton M, Strain EC, Vorsanger G, Wasan AD, Weiss RD, Turk DC, Dworkin RH. Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations. Pain. 2013 Nov; 154(11):2287-96. PMID: 23792283.
    Citations: 26     Fields:    Translation:Humans
  59. Kiluk BD, Dreifuss JA, Weiss RD, Horigian VE, Carroll KM. Psychometric properties of a Spanish-language version of the Short Inventory of Problems. Psychol Addict Behav. 2013 Sep; 27(3):893-900. PMID: 23772760; PMCID: PMC3820151.
    Citations: 1     Fields:    Translation:Humans
  60. Schuman-Olivier Z, Hoeppner BB, Weiss RD, Borodovsky J, Shaffer HJ, Albanese MJ. Benzodiazepine use during buprenorphine treatment for opioid dependence: clinical and safety outcomes. Drug Alcohol Depend. 2013 Oct 01; 132(3):580-6. PMID: 23688843; PMCID: PMC3916951.
    Citations: 11     Fields:    Translation:Humans
  61. Hill KP, Toto LH, Lukas SE, Weiss RD, Trksak GH, Rodolico JM, Greenfield SF. Cognitive behavioral therapy and the nicotine transdermal patch for dual nicotine and cannabis dependence: a pilot study. Am J Addict. 2013 May-Jun; 22(3):233-8. PMID: 23617864; PMCID: PMC3641687.
    Citations: 9     Fields:    Translation:HumansCTClinical Trials
  62. Schuman-Olivier Z, Connery H, Griffin ML, Wyatt SA, Wartenberg AA, Borodovsky J, Renner JA, Weiss RD. Clinician beliefs and attitudes about buprenorphine/naloxone diversion. Am J Addict. 2013 Nov-Dec; 22(6):574-80. PMID: 24131165; PMCID: PMC3801272.
    Citations: 5     Fields:    Translation:Humans
  63. Katz NP, Birnbaum H, Brennan MJ, Freedman JD, Gilmore GP, Jay D, Kenna GA, Madras BK, McElhaney L, Weiss RD, White AG. Prescription opioid abuse: challenges and opportunities for payers. Am J Manag Care. 2013 Apr; 19(4):295-302. PMID: 23725361; PMCID: PMC3680126.
    Citations: 10     Fields:    Translation:HumansPHPublic Health
  64. Hill KP, Bennett HE, Griffin ML, Connery HS, Fitzmaurice GM, Subramaniam G, Woody GE, Weiss RD. Association of cannabis use with opioid outcomes among opioid-dependent youth. Drug Alcohol Depend. 2013 Sep 01; 132(1-2):342-5. PMID: 23528523; PMCID: PMC3724203.
    Citations: 7     Fields:    Translation:HumansPHPublic Health
  65. Levy B, Medina AM, Weiss RD. Cognitive and psychosocial functioning in bipolar disorder with and without psychosis during early remission from an acute mood episode: a comparative longitudinal study. Compr Psychiatry. 2013 Aug; 54(6):618-26. PMID: 23357126; PMCID: PMC4076957.
    Citations: 1     Fields:    Translation:Humans
  66. Dreifuss JA, Griffin ML, Frost K, Fitzmaurice GM, Potter JS, Fiellin DA, Selzer J, Hatch-Maillette M, Sonne SC, Weiss RD. Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study. Drug Alcohol Depend. 2013 Jul 01; 131(1-2):112-8. PMID: 23333292; PMCID: PMC3638044.
    Citations: 29     Fields:    Translation:HumansCTClinical Trials
  67. McHugh RK, Devito EE, Dodd D, Carroll KM, Potter JS, Greenfield SF, Connery HS, Weiss RD. Gender differences in a clinical trial for prescription opioid dependence. J Subst Abuse Treat. 2013 Jul; 45(1):38-43. PMID: 23313145; PMCID: PMC3626739.
    Citations: 23     Fields:    Translation:Humans
  68. Weiss RD. Contingency management for patients with serious mental illness and stimulant dependence. Am J Psychiatry. 2013 Jan; 170(1):6-8. PMID: 23288383.
    Citations:    Fields:    Translation:Humans
  69. McHugh RK, Kaufman JS, Frost KH, Fitzmaurice GM, Weiss RD. Positive affect and stress reactivity in alcohol-dependent outpatients. J Stud Alcohol Drugs. 2013 Jan; 74(1):152-7. PMID: 23200161; PMCID: PMC3517258.
    Citations: 7     Fields:    Translation:Humans
  70. DeVido JJ, Weiss RD. Treatment of the depressed alcoholic patient. Curr Psychiatry Rep. 2012 Dec; 14(6):610-8. PMID: 22907336; PMCID: PMC3712746.
    Citations: 3     Fields:    Translation:Humans
  71. Farren CK, Hill KP, Weiss RD. Bipolar disorder and alcohol use disorder: a review. Curr Psychiatry Rep. 2012 Dec; 14(6):659-66. PMID: 22983943; PMCID: PMC3730445.
    Citations: 9     Fields:    Translation:Humans
  72. Hill KP, Rice LS, Connery HS, Weiss RD. Diagnosing and treating opioid dependence. J Fam Pract. 2012 Oct; 61(10):588-97. PMID: 23106060.
    Citations:    Fields:    Translation:Humans
  73. Keuroghlian AS, Barry AS, Weiss RD. Circadian dysregulation, zolpidem dependence, and withdrawal seizure in a resident physician performing shift work. Am J Addict. 2012 Nov-Dec; 21(6):576-7. PMID: 23082842; PMCID: PMC3744365.
    Citations: 3     Fields:    Translation:Humans
  74. Turk DC, O'Connor AB, Dworkin RH, Chaudhry A, Katz NP, Adams EH, Brownstein JS, Comer SD, Dart R, Dasgupta N, Denisco RA, Klein M, Leiderman DB, Lubran R, Rappaport BA, Zacny JP, Ahdieh H, Burke LB, Cowan P, Jacobs P, Malamut R, Markman J, Michna E, Palmer P, Peirce-Sandner S, Potter JS, Raja SN, Rauschkolb C, Roland CL, Webster LR, Weiss RD, Wolf K. Research design considerations for clinical studies of abuse-deterrent opioid analgesics: IMMPACT recommendations. Pain. 2012 Oct; 153(10):1997-2008. PMID: 22770841; PMCID: PMC3617214.
    Citations: 9     Fields:    Translation:Humans
  75. Kiluk BD, Dreifuss JA, Weiss RD, Morgenstern J, Carroll KM. The Short Inventory of Problems - revised (SIP-R): psychometric properties within a large, diverse sample of substance use disorder treatment seekers. Psychol Addict Behav. 2013 Mar; 27(1):307-14. PMID: 22642856; PMCID: PMC3434306.
    Citations: 11     Fields:    Translation:Humans
  76. Levy B, Manove E, Weiss RD. Recovery of cognitive functioning in patients with co-occurring bipolar disorder and alcohol dependence during early remission from an acute mood episode. Ann Clin Psychiatry. 2012 May; 24(2):143-54. PMID: 22563570; PMCID: PMC3349462.
    Citations: 2     Fields:    Translation:Humans
  77. Copersino ML, Schretlen DJ, Fitzmaurice GM, Lukas SE, Faberman J, Sokoloff J, Weiss RD. Effects of cognitive impairment on substance abuse treatment attendance: predictive validation of a brief cognitive screening measure. Am J Drug Alcohol Abuse. 2012 May; 38(3):246-50. PMID: 22443860; PMCID: PMC3593077.
    Citations: 4     Fields:    Translation:Humans
  78. Wasan AD, Ross EL, Michna E, Chibnik L, Greenfield SF, Weiss RD, Jamison RN. Craving of prescription opioids in patients with chronic pain: a longitudinal outcomes trial. J Pain. 2012 Feb; 13(2):146-54. PMID: 22245713; PMCID: PMC3274819.
    Citations: 18     Fields:    Translation:Humans
  79. Putnins SI, Griffin ML, Fitzmaurice GM, Dodd DR, Weiss RD. Poor sleep at baseline predicts worse mood outcomes in patients with co-occurring bipolar disorder and substance dependence. J Clin Psychiatry. 2012 May; 73(5):703-8. PMID: 22313797; PMCID: PMC3349805.
    Citations: 3     Fields:    Translation:Humans
  80. Kolodziej ME, Muchowski PM, Hamdi NR, Morrissette P, McGowan AJ, Weiss RD. Adaptation of the patient feedback survey at a community treatment setting. Am J Addict. 2012 Jan-Feb; 21(1):63-71. PMID: 22211348; PMCID: PMC3699190.
    Citations:    Fields:    Translation:Humans
  81. Weiss RD, Potter JS, Fiellin DA, Byrne M, Connery HS, Dickinson W, Gardin J, Griffin ML, Gourevitch MN, Haller DL, Hasson AL, Huang Z, Jacobs P, Kosinski AS, Lindblad R, McCance-Katz EF, Provost SE, Selzer J, Somoza EC, Sonne SC, Ling W. Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial. Arch Gen Psychiatry. 2011 Dec; 68(12):1238-46. PMID: 22065255; PMCID: PMC3470422.
    Citations: 114     Fields:    Translation:Humans
  82. Meade CS, Fitzmaurice GM, Sanchez AK, Griffin ML, McDonald LJ, Weiss RD. The relationship of manic episodes and drug abuse to sexual risk behavior in patients with co-occurring bipolar and substance use disorders: a 15-month prospective analysis. AIDS Behav. 2011 Nov; 15(8):1829-33. PMID: 20859672; PMCID: PMC3191230.
    Citations: 5     Fields:    Translation:Humans
  83. Subramaniam GA, Warden D, Minhajuddin A, Fishman MJ, Stitzer ML, Adinoff B, Trivedi M, Weiss R, Potter J, Poole SA, Woody GE. Predictors of abstinence: National Institute of Drug Abuse multisite buprenorphine/naloxone treatment trial in opioid-dependent youth. J Am Acad Child Adolesc Psychiatry. 2011 Nov; 50(11):1120-8. PMID: 22024000.
    Citations: 15     Fields:    Translation:HumansPHPublic Health
  84. Ittiwut C, Yang BZ, Kranzler HR, Anton RF, Hirunsatit R, Weiss RD, Covault J, Farrer LA, Gelernter J. GABRG1 and GABRA2 variation associated with alcohol dependence in African Americans. Alcohol Clin Exp Res. 2012 Apr; 36(4):588-93. PMID: 21919924; PMCID: PMC3250564.
    Citations: 20     Fields:    Translation:Humans
  85. Carroll KM, Ball SA, Jackson R, Martino S, Petry NM, Stitzer ML, Wells EA, Weiss RD. Ten take home lessons from the first 10 years of the CTN and 10 recommendations for the future. Am J Drug Alcohol Abuse. 2011 Sep; 37(5):275-82. PMID: 21854269; PMCID: PMC3232679.
    Citations: 4     Fields:    Translation:Humans
  86. Potter JS, Donovan DM, Weiss RD, Gardin J, Lindblad R, Wakim P, Dodd D. Site selection in community-based clinical trials for substance use disorders: strategies for effective site selection. Am J Drug Alcohol Abuse. 2011 Sep; 37(5):400-7. PMID: 21854283; PMCID: PMC3160724.
    Citations: 8     Fields:    Translation:Humans
  87. Teter CJ, Falone AE, Bakaian AM, Tu C, Ongür D, Weiss RD. Medication adherence and attitudes in patients with bipolar disorder and current versus past substance use disorder. Psychiatry Res. 2011 Dec 30; 190(2-3):253-8. PMID: 21696830; PMCID: PMC3663075.
    Citations: 8     Fields:    Translation:Humans
  88. Ittiwut R, Listman JB, Ittiwut C, Cubells JF, Weiss RD, Brady K, Oslin D, Farrer LA, Kranzler HR, Gelernter J. Association between polymorphisms in catechol-O-methyltransferase (COMT) and cocaine-induced paranoia in European-American and African-American populations. Am J Med Genet B Neuropsychiatr Genet. 2011 Sep; 156B(6):651-60. PMID: 21656904; PMCID: PMC3864552.
    Citations: 13     Fields:    Translation:Humans
  89. Hamdi NR, Levy M, Jaffee WB, Chisholm SM, Weiss RD. Implementing an adapted version of the job seekers' workshop in a residential program for patients with substance use disorders. J Addict Med. 2011 Jun; 5(2):148-52. PMID: 21643458; PMCID: PMC3107016.
    Citations:    Fields:    Translation:Humans
  90. Levy B, Medina AM, Manove E, Weiss RD. The characteristics of a discrete mood episode, neuro-cognitive impairment and re-hospitalization in bipolar disorder. J Psychiatr Res. 2011 Aug; 45(8):1048-54. PMID: 21306735; PMCID: PMC3194763.
    Citations: 3     Fields:    Translation:Humans
  91. McDonald LJ, Griffin ML, Kolodziej ME, Fitzmaurice GM, Weiss RD. The impact of drug use in social networks of patients with substance use and bipolar disorders. Am J Addict. 2011 Mar-Apr; 20(2):100-5. PMID: 21314751; PMCID: PMC3071143.
    Citations: 7     Fields:    Translation:Humans
  92. Levy S, Knight JR, Moore T, Weinstein Z, Sherritt L, Weiss RD. Acceptability of drug testing in an outpatient substance abuse program for adolescents. J Adolesc Health. 2011 Mar; 48(3):229-33. PMID: 21338892; PMCID: PMC3052946.
    Citations: 2     Fields:    Translation:Humans
  93. Zanarini MC, Frankenburg FR, Frankenbur FR, Weingeroff JL, Reich DB, Fitzmaurice GM, Weiss RD. The course of substance use disorders in patients with borderline personality disorder and Axis II comparison subjects: a 10-year follow-up study. Addiction. 2011 Feb; 106(2):342-8. PMID: 21083831; PMCID: PMC3222933.
    Citations: 14     Fields:    Translation:Humans
  94. Meade CS, Weiss RD, Fitzmaurice GM, Poole SA, Subramaniam GA, Patkar AA, Connery HS, Woody GE. HIV risk behavior in treatment-seeking opioid-dependent youth: results from a NIDA clinical trials network multisite study. J Acquir Immune Defic Syndr. 2010 Sep; 55(1):65-72. PMID: 20393347; PMCID: PMC3148945.
    Citations: 10     Fields:    Translation:Humans
  95. Levy B, Medina AM, Hintz K, Weiss RD. Ecologically valid support for the link between cognitive and psychosocial functioning in bipolar disorder. Psychiatry Res. 2011 Feb 28; 185(3):353-7. PMID: 20674041; PMCID: PMC3146310.
    Citations:    Fields:    Translation:Humans
  96. Upadhyay J, Maleki N, Potter J, Elman I, Rudrauf D, Knudsen J, Wallin D, Pendse G, McDonald L, Griffin M, Anderson J, Nutile L, Renshaw P, Weiss R, Becerra L, Borsook D. Alterations in brain structure and functional connectivity in prescription opioid-dependent patients. Brain. 2010 Jul; 133(Pt 7):2098-114. PMID: 20558415; PMCID: PMC2912691.
    Citations: 74     Fields:    Translation:HumansCTClinical Trials
  97. Potter JS, Chakrabarti A, Domier CP, Hillhouse MP, Weiss RD, Ling W. Pain and continued opioid use in individuals receiving buprenorphine-naloxone for opioid detoxification: secondary analyses from the Clinical Trials Network. J Subst Abuse Treat. 2010 Jun; 38 Suppl 1:S80-6. PMID: 20307799; PMCID: PMC3150507.
    Citations: 14     Fields:    Translation:Humans
  98. Ling W, Jacobs P, Hillhouse M, Hasson A, Thomas C, Freese T, Sparenborg S, McCarty D, Weiss R, Saxon A, Cohen A, Straus M, Brigham G, Liu D, McLaughlin P, Tai B. From research to the real world: buprenorphine in the decade of the Clinical Trials Network. J Subst Abuse Treat. 2010 Jun; 38 Suppl 1:S53-60. PMID: 20307796; PMCID: PMC2853172.
    Citations: 15     Fields:    Translation:Humans
  99. Winhusen TM, Somoza EC, Brigham GS, Liu DS, Green CA, Covey LS, Croghan IT, Adler LA, Weiss RD, Leimberger JD, Lewis DF, Dorer EM. Impact of attention-deficit/hyperactivity disorder (ADHD) treatment on smoking cessation intervention in ADHD smokers: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2010 Dec; 71(12):1680-8. PMID: 20492837; PMCID: PMC3151610.
    Citations: 44     Fields:    Translation:Humans
  100. Liebschutz JM, Saitz R, Weiss RD, Averbuch T, Schwartz S, Meltzer EC, Claggett-Borne E, Cabral H, Samet JH. Clinical factors associated with prescription drug use disorder in urban primary care patients with chronic pain. J Pain. 2010 Nov; 11(11):1047-55. PMID: 20338815; PMCID: PMC2892730.
    Citations: 22     Fields:    Translation:Humans
  101. Weiss RD, Potter JS, Copersino ML, Prather K, Jacobs P, Provost S, Chim D, Selzer J, Ling W. Conducting clinical research with prescription opioid dependence: defining the population. Am J Addict. 2010 Mar-Apr; 19(2):141-6. PMID: 20163386; PMCID: PMC2852106.
    Citations: 11     Fields:    Translation:Humans
  102. Panhuysen CI, Kranzler HR, Yu Y, Weiss RD, Brady K, Poling J, Farrer LA, Gelernter J. Confirmation and generalization of an alcohol-dependence locus on chromosome 10q. Neuropsychopharmacology. 2010 May; 35(6):1325-32. PMID: 20147890; PMCID: PMC2855759.
    Citations: 6     Fields:    Translation:HumansCells
  103. Weiss RD, Potter JS, Provost SE, Huang Z, Jacobs P, Hasson A, Lindblad R, Connery HS, Prather K, Ling W. A multi-site, two-phase, Prescription Opioid Addiction Treatment Study (POATS): rationale, design, and methodology. Contemp Clin Trials. 2010 Mar; 31(2):189-99. PMID: 20116457; PMCID: PMC2831115.
    Citations: 34     Fields:    Translation:Humans
  104. Potter JS, Prather K, Kropp F, Byrne M, Sullivan CR, Mohamedi N, Copersino ML, Weiss RD. A method to diagnose opioid dependence resulting from heroin versus prescription opioids using the Composite International Diagnostic Interview. Contemp Clin Trials. 2010 Mar; 31(2):185-8. PMID: 20079463; PMCID: PMC3579622.
    Citations: 4     Fields:    Translation:Humans
  105. Ostacher MJ, Perlis RH, Nierenberg AA, Calabrese J, Stange JP, Salloum I, Weiss RD, Sachs GS. Impact of substance use disorders on recovery from episodes of depression in bipolar disorder patients: prospective data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry. 2010 Mar; 167(3):289-97. PMID: 20008948; PMCID: PMC2918249.
    Citations: 17     Fields:    Translation:HumansPHPublic Health
  106. Chakrabarti A, Woody GE, Griffin ML, Subramaniam G, Weiss RD. Predictors of buprenorphine-naloxone dosing in a 12-week treatment trial for opioid-dependent youth: secondary analyses from a NIDA Clinical Trials Network study. Drug Alcohol Depend. 2010 Mar 01; 107(2-3):253-6. PMID: 19948382; PMCID: PMC2821971.
    Citations: 11     Fields:    Translation:Humans
  107. Kalayasiri R, Gelernter J, Farrer L, Weiss R, Brady K, Gueorguieva R, Kranzler HR, Malison RT. Adolescent cannabis use increases risk for cocaine-induced paranoia. Drug Alcohol Depend. 2010 Mar 01; 107(2-3):196-201. PMID: 19944543; PMCID: PMC2821949.
    Citations: 2     Fields:    Translation:HumansAnimals
  108. Levy B, Weiss RD. Neurocognitive impairment and psychosis in bipolar I disorder during early remission from an acute episode of mood disturbance. J Clin Psychiatry. 2010 Feb; 71(2):201-6. PMID: 19925749; PMCID: PMC3143061.
    Citations: 6     Fields:    Translation:Humans
  109. Xie P, Kranzler HR, Poling J, Stein MB, Anton RF, Brady K, Weiss RD, Farrer L, Gelernter J. Interactive effect of stressful life events and the serotonin transporter 5-HTTLPR genotype on posttraumatic stress disorder diagnosis in 2 independent populations. Arch Gen Psychiatry. 2009 Nov; 66(11):1201-9. PMID: 19884608; PMCID: PMC2867334.
    Citations: 88     Fields:    Translation:Humans
  110. Copersino ML, Fals-Stewart W, Fitzmaurice G, Schretlen DJ, Sokoloff J, Weiss RD. Rapid cognitive screening of patients with substance use disorders. Exp Clin Psychopharmacol. 2009 Oct; 17(5):337-44. PMID: 19803633; PMCID: PMC3144764.
    Citations: 15     Fields:    Translation:HumansPHPublic Health
  111. Douglas KR, Chan G, Gelernter J, Arias AJ, Anton RF, Weiss RD, Brady K, Poling J, Farrer L, Kranzler HR. Adverse childhood events as risk factors for substance dependence: partial mediation by mood and anxiety disorders. Addict Behav. 2010 Jan; 35(1):7-13. PMID: 19720467; PMCID: PMC2763992.
    Citations: 34     Fields:    Translation:Humans
  112. Niciu MJ, Chan G, Gelernter J, Arias AJ, Douglas K, Weiss R, Anton RF, Farrer L, Cubells JF, Kranzler HR. Subtypes of major depression in substance dependence. Addiction. 2009 Oct; 104(10):1700-9. PMID: 19681804; PMCID: PMC2980795.
    Citations: 5     Fields:    Translation:Humans
  113. Weiss RD, Griffin ML, Jaffee WB, Bender RE, Graff FS, Gallop RJ, Fitzmaurice GM. A "community-friendly" version of integrated group therapy for patients with bipolar disorder and substance dependence: a randomized controlled trial. Drug Alcohol Depend. 2009 Oct 01; 104(3):212-9. PMID: 19573999; PMCID: PMC2735139.
    Citations: 24     Fields:    Translation:Humans
  114. Meade CS, Lukas SE, McDonald LJ, Fitzmaurice GM, Eldridge JA, Merrill N, Weiss RD. A randomized trial of transcutaneous electric acupoint stimulation as adjunctive treatment for opioid detoxification. J Subst Abuse Treat. 2010 Jan; 38(1):12-21. PMID: 19574017; PMCID: PMC2789908.
    Citations: 10     Fields:    Translation:Humans
  115. Meade CS, McDonald LJ, Weiss RD. HIV risk behavior in opioid dependent adults seeking detoxification treatment: an exploratory comparison of heroin and oxycodone users. Am J Addict. 2009 Jul-Aug; 18(4):289-93. PMID: 19444732; PMCID: PMC2905052.
    Citations: 9     Fields:    Translation:Humans
  116. Wu LT, Ringwalt CL, Weiss RD, Blazer DG. Hallucinogen-related disorders in a national sample of adolescents: the influence of ecstasy/MDMA use. Drug Alcohol Depend. 2009 Sep 01; 104(1-2):156-66. PMID: 19500920; PMCID: PMC2733917.
    Citations: 2     Fields:    Translation:Humans
  117. Hughes JR, Weiss RD. Are differences in guidelines for the treatment of nicotine dependence and non-nicotine dependence justified? Addiction. 2009 Dec; 104(12):1951-7. PMID: 19426290; PMCID: PMC3127200.
    Citations: 2     Fields:    Translation:Humans
  118. Meade CS, McDonald LJ, Graff FS, Fitzmaurice GM, Griffin ML, Weiss RD. A prospective study examining the effects of gender and sexual/physical abuse on mood outcomes in patients with co-occurring bipolar I and substance use disorders. Bipolar Disord. 2009 Jun; 11(4):425-33. PMID: 19392857; PMCID: PMC2908240.
    Citations: 7     Fields:    Translation:Humans
  119. McGovern MP, Lambert-Harris C, Acquilano S, Xie H, Alterman AI, Weiss RD. A cognitive behavioral therapy for co-occurring substance use and posttraumatic stress disorders. Addict Behav. 2009 Oct; 34(10):892-7. PMID: 19395179; PMCID: PMC2720425.
    Citations: